IL6 and melanoma: The significance of STAT3 activation in the melanoma-microglia crosstalk was highlighted by findings that the IL-6/JAK/STAT3 pathway inhibitors restrained the melanoma-mediated activation of microglial STAT3 as well as the up-regulation of SOCS3 in microglia cells exposed to melanoma soluble factors.